- 全部删除
您的购物车当前为空
Tigulixostat (LC350189) 是一种新型黄嘌呤氧化酶抑制剂(XOI),可降低尿酸生成,可用于研究痛风相关的疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
Tigulixostat (LC350189) 是一种新型黄嘌呤氧化酶抑制剂(XOI),可降低尿酸生成,可用于研究痛风相关的疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,290 | In stock | |
| 5 mg | ¥ 2,880 | In stock | |
| 10 mg | ¥ 4,630 | In stock | |
| 25 mg | ¥ 7,150 | In stock | |
| 50 mg | ¥ 9,630 | In stock | |
| 100 mg | ¥ 12,900 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 3,190 | In stock |
Tigulixostat 相关产品
| 产品描述 | Tigulixostat (LC350189) is a novel xanthine oxidase inhibitor (XOI) that reduces uric acid production and may be used in studies of gout-related diseases. |
| 别名 | 替古索司他, LC350189 |
| 分子量 | 294.31 |
| 分子式 | C16H14N4O2 |
| CAS No. | 1287766-55-5 |
| Smiles | CC(C)n1cc(C#N)c2cc(ccc12)-n1cc(cn1)C(O)=O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (271.82 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容